Intelligent Bio Solutions Inc (NAS:INBS)
$ 1.61 -0.09 (-5.23%) Market Cap: 6.84 Mil Enterprise Value: 1.88 Mil PE Ratio: 0 PB Ratio: 0.71 GF Score: 35/100

Q4 2021 Gbs Inc Earnings Call Transcript

Aug 11, 2021 / 08:30PM GMT
Release Date Price: $748.8 (+2.30%)
Operator

Greetings, and welcome to the GBS Inc. Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Alex Arzeno, Investor Relations for GBS. Thank you. You may begin.

Alex Arzeno
GBS Inc. - VP of IR

Thank you, and good afternoon. Joining us today from the company are Harry Simeonidis, President and CEO; and Spiro Sakiris, Chief Financial Officer. A press release announcing the results and the update was issued this afternoon and is available now on the GBS website.

I will now read the company's safe harbor statement. Some of the statements on this conference call are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act of 1995, which involves risks and uncertainties. Forward-looking statements on this call include, without limitation, GBS Inc.'s ability to develop and commercialize its diagnostic tests, realize

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot